substance p and Neurodegenerative Diseases
substance p has been researched along with Neurodegenerative Diseases in 4 studies
Research
Studies (4)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Balemba, OB; Gericke, M; Horton, S; Kappmeyer, AJ; Nyavor, YE; Stenkamp-Strahm, CM | 1 |
Antonioli, L; Bernardini, N; Blandini, F; Blandizzi, C; Cerri, S; Colucci, R; Cseri, K; Fornai, M; Haskó, G; Ippolito, C; Levandis, G; Pellegrini, C; Segnani, C; Tirotta, E | 1 |
Blackabey, V; Denes, A; Gittens, B; Pinteaux, E; Rodriguez-Grande, B | 1 |
Dickinson, T; Fleetwood-Walker, SM | 1 |
Other Studies
4 other study(ies) available for substance p and Neurodegenerative Diseases
Article | Year |
---|---|
Prolonged high fat diet ingestion, obesity, and type 2 diabetes symptoms correlate with phenotypic plasticity in myenteric neurons and nerve damage in the mouse duodenum.
Topics: Animals; Apoptosis; Diabetes Mellitus, Type 2; Diet, High-Fat; Duodenum; Enteric Nervous System; Insulin Resistance; Mice; Mice, Inbred C57BL; Myenteric Plexus; Neurodegenerative Diseases; Neurons; Nitric Oxide Synthase; Obesity; Substance P | 2015 |
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration.
Topics: Animals; Benzoxazoles; Disease Models, Animal; Dopamine; Enteric Nervous System; Eosinophils; Gastrointestinal Diseases; Gastrointestinal Motility; Glial Fibrillary Acidic Protein; Indoles; Male; Mast Cells; Neurodegenerative Diseases; Oxidopamine; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P; Sympatholytics; Tyrosine 3-Monooxygenase | 2016 |
Loss of substance P and inflammation precede delayed neurodegeneration in the substantia nigra after cerebral ischemia.
Topics: Animals; Brain Ischemia; Cell Death; Coloring Agents; Dopaminergic Neurons; Immunohistochemistry; Infarction, Middle Cerebral Artery; Inflammation; Male; Mice; Mice, Inbred C57BL; Motor Activity; Neostriatum; Neurodegenerative Diseases; Receptors, Neurokinin-1; Substance P; Substantia Nigra | 2013 |
Neuropeptides and nociception: recent advances and therapeutic implications.
Topics: Analgesia; Animals; Animals, Genetically Modified; Humans; Neurodegenerative Diseases; Neuropeptides; Receptors, Neuropeptide; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide; Receptors, Pituitary Hormone; Receptors, Vasoactive Intestinal Peptide; Substance P; Synaptic Transmission | 1998 |